Amesite Inc., a leading artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university, nonprofit, and government agency learning and upskilling, announced the pricing of its “best efforts” underwritten public offering of 3,437,500 shares of its common stock at a public offering price of $0.80 per share, before underwriting discounts and commissions, for an aggregate offering of approximately $2.75 million. The offering is expected to close on February 16, 2022, subject to the satisfaction of customary closing conditions.
Also Read: Arkuda Raises $64 Million Series B Financing to Advance Pipeline of Programs
Laidlaw & Company (UK) Ltd. is acting as sole book-running manager for the offering.
Amesite intends to use the net proceeds from the offering for general corporate purposes, capital expenditures, working capital and general and administrative expenses.
A shelf registration statement on Form S-3 (Registration No. 333-260666) relating to the public offering of the shares of common stock described above was previously filed with the Securities and Exchange Commission (SEC) and declared effective on November 1, 2021. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement, when available, and accompanying prospectus relating to the offering may be obtained from Laidlaw & Company (UK) Ltd., 521 Fifth Ave., 12th Floor, New York, NY 10175, Attention: Syndicate Dept.; email: syndicate@laidlawltd.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means of the prospectus supplement and accompanying prospectus forming a part of the effective registration statement.